Codes ATC:
A04AD12
EMLc
Indication
Nausea or vomiting
Code ICD11:
MG10
INN
Aprepitant
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Liquid:
125 mg powder for oral suspension (in sachet)
Oral > Solid > capsule: 80 mg (EML) ; 125 mg (EML) ; 165 mg (EML)
Oral > Solid > capsule: 80 mg (EML) ; 125 mg (EML) ; 165 mg (EML)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the removal from the EMLc of aprepitant capsules (80 mg, 125 mg and 165 mg). These formulations cannot deliver the recommended dose of aprepitant for children aged below 12 years.